In Vitro Diagnostics IVD Market is Projected to grow at a CAGR of 5.2% from 2018 to 2023

“The in vitro diagnostics market is projected to grow at a CAGR of 5.2%.”

The in vitro diagnostics market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness of personalized medicine, and increasing adoption of fully-automated instruments and automation in laboratories. Moreover, the development of condition-specific markers and tests, growing significance of companion diagnostics, and emerging economies are expected to offer significant growth opportunities for market players during the forecast period. However, the unfavorable reimbursement scenario, changing regulatory landscape, and operational barriers faced in conducting diagnostic tests are all expected to challenge market growth to a certain extent in the coming years.

 

Request a Free Sample copy of This Premium Research Report:  https://watchersofmarkets.com/products/in-vitro-diagnostics-ivd-market-by-product-instruments-reagents-technology-immunoassay-clinical-chemistry-molecular-diagnostics-hematology-urinalysis-application-diabetes-oncology-cardiology-nephrology-forecast-to-2023#tab-questions

 

“The reagents & kits segment is expected to dominate the market during the forecast period.”

In 2018, on the basis of product & service, the reagents & kits segment is expected to account for the largest share of the market.The large share of this segment is primarily attributed to the increased accessibility and demand for reagents and the rising number of IVD tests conducted.

 

“The oncology segment is projected to be the fastest growing during the forecast period.”

In 2018, on the basis of application, the oncology segment is expected to register the highest growth rate during the forecast period, owing to the increasing prevalence of cancer and the introduction of a number of diagnostic tests such as Oncomine Dx Target Test and Oncomine Solid Tumor kits (Thermo Fisher Scientific) for NSCLC and PTEN/ERG FISH and UroVysion FISH tests for the detection of bladder cancer and treatment assessment of prostate cancer.

 

“Asia Pacific is expected to register the highest growth rate during the forecast period.”

In this report, the IVD market is divided into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period owing to the huge demand for better healthcare services; increasing incidence of chronic and infectious diseases; rapid development in the healthcare infrastructure of developing countries such as India, China, and South Korea; growing healthcare research investments in this region; and increasing per capita income of the middle-class population in the region.

 

Read more on this report:  https://watchersofmarkets.com/products/in-vitro-diagnostics-ivd-market-by-product-instruments-reagents-technology-immunoassay-clinical-chemistry-molecular-diagnostics-hematology-urinalysis-application-diabetes-oncology-cardiology-nephrology-forecast-to-2023

 

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type – Tier 1 – 22%, Tier 2 – 53% and Tier 3 – 25%
  • By Designation – C-level – 45%, Director-level – 30%, Others – 25%
  • By Region – North America – 55%, Europe – 25%, APAC – 10%, Latin America– 5%, and Middle East & Africa – 5%

 

List of companies profiled in the report

 

  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (Germany)
  • Danaher Corporation (US)
  • Abbott Laboratories (US)
  • Thermo Fisher Scientific (US)
  • Johnson & Johnson (US)
  • Becton, Dickinson and Company (US)
  • Bio-Rad Laboratories (US)
  • Sysmex Corporation (Japan) and others

 

Related Report:

Global In Vitro Diagnostics(Ivd) Industry Market Research Report

The In Vitro Diagnostics(Ivd) market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the In Vitro Diagnostics(Ivd) industrial chain, this report mainly elaborate the definition, types, applications and major players of In Vitro Diagnostics(Ivd) market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the In Vitro Diagnostics(Ivd) market.

Read More: https://watchersofmarkets.com/products/global-in-vitro-diagnosticsivd-industry-market-research-report

About Us:

We are a leading market research store (headquartered in The Hague, Netherlands) bringing to you market research insights, analysis and data from many market research publishers around the globe.

Our experienced market research consultants understand a client’s research requirements in precise manner and get as many proposals around the globe as possible on the table suiting your budget and mapping your research goals.

Our only motivation is to provide clients with precise insights into their respective niche markets and offering them the most comprehensive portfolio of business information products.

 

Contact:

Watchers of Markets

Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.

Website: https://watchersofmarkets.com/

Phone number: +31- 85 888 111 6

Email Id : [email protected]

Posted by on Saturday September 15 2018, 9:04 AM EDT. All trademarks acknowledged. Filed under Biotechnology, Business & Financial Services, Business Services, Diagnostics, Featured Press Release, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals, Technology Hardware & Equipment, Technology, Media, & Telecommunications. Comments and Trackbacks are open. Follow responses: RSS 2.0

Leave a Reply

News Categories

Featured Press Releases

Log in